LeMaitre Vascular (LMAT) Competitors

LeMaitre Vascular (NASDAQ:LMAT) and Stevanato Group (NYSE:STVN) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, community ranking, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends.

Is LMAT or STVN more profitable?

LeMaitre Vascular has a net margin of 19.40% compared to Stevanato Group's net margin of 10.47%. LeMaitre Vascular's return on equity of 13.15% beat Stevanato Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LeMaitre Vascular	19.40%	13.15%	11.47%
Stevanato Group	10.47%	9.86%	5.79%

Is LMAT or STVN a better dividend stock?

LeMaitre Vascular pays an annual dividend of $0.80 per share and has a dividend yield of 0.9%. Stevanato Group pays an annual dividend of €0.06 per share and has a dividend yield of 0.3%. LeMaitre Vascular pays out 41.2% of its earnings in the form of a dividend. Stevanato Group pays out 12.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. LeMaitre Vascular has increased its dividend for 14 consecutive years. LeMaitre Vascular is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Do insiders & institutionals have more ownership in LMAT or STVN?

84.6% of LeMaitre Vascular shares are owned by institutional investors. 10.8% of LeMaitre Vascular shares are owned by insiders. Comparatively, 0.7% of Stevanato Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Do analysts rate LMAT or STVN?

LeMaitre Vascular currently has a consensus target price of $95.25, suggesting a potential upside of 11.95%. Given LeMaitre Vascular's higher probable upside, equities analysts clearly believe LeMaitre Vascular is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LeMaitre Vascular	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.67
Stevanato Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

Does the media refer more to LMAT or STVN?

In the previous week, Stevanato Group had 1 more articles in the media than LeMaitre Vascular. MarketBeat recorded 8 mentions for Stevanato Group and 7 mentions for LeMaitre Vascular. LeMaitre Vascular's average media sentiment score of 1.48 beat Stevanato Group's score of 1.21 indicating that LeMaitre Vascular is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LeMaitre Vascular	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Stevanato Group	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer LMAT or STVN?

LeMaitre Vascular received 485 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 70.45% of users gave LeMaitre Vascular an outperform vote while only 62.50% of users gave Stevanato Group an outperform vote.

Company	Underperform	Outperform
LeMaitre Vascular	Outperform Votes 515 70.45%	Underperform Votes 216 29.55%
Stevanato Group	Outperform Votes 30 62.50%	Underperform Votes 18 37.50%

Which has stronger valuation & earnings, LMAT or STVN?

Stevanato Group has higher revenue and earnings than LeMaitre Vascular. LeMaitre Vascular is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LeMaitre Vascular	$219.86M	8.73	$30.10M	$1.94	43.86
Stevanato Group	$1.10B	5.83	$157.62M	$0.48	44.29

Which has more risk and volatility, LMAT or STVN?

LeMaitre Vascular has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500.

Summary

LeMaitre Vascular beats Stevanato Group on 16 of the 22 factors compared between the two stocks.